Greg Nogle is driven by a commitment to advancing reimbursement strategies and payer integration, making him an ideal fit for his role as Vice President of Market Access at Ambry Genetics. In this position, Greg leads efforts to integrate coverage initiatives with CMS/Medicare contractors and drive reimbursement strategies for commercial and government payers. Prior to joining Ambry, Greg held leadership roles in medical device, therapeutics, and diagnostics industries, including positions at Insulet Corporation and Roche Diagnostics. He holds a B.S. from LSU, where he focused on economics and history.